DINA PEREPELYUK: Open Payments
NPI 1952513574 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 10 payments from 3 companies in 2025. Trend: 2023 $65 · 2024 $502 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $348 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $22 |
Products named: DUPIXENT, TEZSPIRE, NUCALA.
Industry payments across NY — which companies pay providers there.
